Pages that link to "Q36956632"
Jump to navigation
Jump to search
The following pages link to Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. (Q36956632):
Displaying 20 items.
- Genetics of Common Antipsychotic-Induced Adverse Effects (Q28072893) (← links)
- Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder (Q36853567) (← links)
- Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis (Q37648311) (← links)
- Genetics of antipsychotic-induced weight gain: update and current perspectives (Q38166456) (← links)
- An update on medication management of behavioral disorders in autism (Q38184482) (← links)
- Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed. (Q38241344) (← links)
- Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder (Q38266796) (← links)
- Pharmacogenomic medicine in autism: challenges and opportunities (Q38270928) (← links)
- Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children (Q38536898) (← links)
- Precision medicine for psychopharmacology: a general introduction (Q38814860) (← links)
- Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes (Q39064271) (← links)
- Pharmacogenomics of autism spectrum disorder (Q39154436) (← links)
- Autism genetics: opportunities and challenges for clinical translation (Q39162331) (← links)
- Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample (Q40590073) (← links)
- Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales? (Q47178969) (← links)
- Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain (Q47211764) (← links)
- Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland. (Q55283481) (← links)
- Associations between the -2548G/A Promoter and Baseline Weight and between Gln223Arg and Lys656Asn Variants and Change in BMI Scores in Arab Children and Adolescents Treated with Risperidone (Q58598653) (← links)
- Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain (Q90752018) (← links)
- Pharmacogenomic Characterization in Bipolar Spectrum Disorders (Q92255814) (← links)